Clinical Trial Update: Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for MEDI6012 assessing multiple ascending doses in adults with stable atherosclerotic cardiovascular disease; results posted after completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease

Drugs mentioned

• MEDI6012

Snippet

Sponsor: MedImmune LLC | Conditions: Atherosclerosis, Cardiovascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-11-30